Feinsod Matthew 4/A
4/A · APPLIED GENETIC TECHNOLOGIES CORP · Filed May 20, 2019
Insider Transaction Report
Form 4/AAmended
Feinsod Matthew
Interim Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2019-05-13$4.06/sh−685$2,781→ 53,329 total
Footnotes (1)
- [F1]This Form 4/A is being filed to correct an administrative error in the reported price of the securities forfeited for tax witholding purposes.